Alnera Aluminium
301613
Tibet Duo Rui Pharmaceutical
301075
ChengDu Sheng Nuo Biotec
688117
4
THEC
833509
5
Shenzhen Jasic Technology
300193
US Stock MarketDetailed Quotes
SLRN Acelyrin
- 2.600
- -0.040-1.52%
Close Mar 28 16:00 ET
- 2.580
- -0.020-0.77%
Post 20:01 ET
261.85MMarket Cap-1.04P/E (TTM)
2.640High2.550Low320.88KVolume2.630Open2.640Pre Close835.43KTurnover0.44%Turnover RatioLossP/E (Static)100.71MShares7.25052wk High0.57P/B188.74MFloat Cap1.84552wk Low--Dividend TTM72.59MShs Float29.880Historical High--Div YieldTTM3.41%Amplitude1.845Historical Low2.603Avg Price1Lot Size
Acelyrin Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -27.77%304.86M | -19.01%85.13M | -53.47%43.94M | 117.88%93.03M | -53.97%82.77M | 510.10%422.06M | 360.78%105.11M | 513.30%94.42M | 186.82%42.7M | 1,018.02%179.83M |
| Selling and administrative expenses | 0.95%66.81M | -39.75%13.1M | -37.94%12.33M | 31.40%16.64M | 107.69%24.74M | 388.51%66.18M | 302.41%21.74M | 587.95%19.86M | 482.08%12.67M | 286.53%11.91M |
| -General and administrative expense | 0.95%66.81M | -39.75%13.1M | -37.94%12.33M | 31.40%16.64M | 107.69%24.74M | 388.51%66.18M | 302.41%21.74M | 587.95%19.86M | 482.08%12.67M | 286.53%11.91M |
| Research and development costs | -33.11%238.06M | -13.61%72.03M | -57.60%31.61M | 154.35%76.38M | -65.44%58.03M | 539.71%355.89M | 378.89%83.37M | 496.07%74.56M | 136.27%30.03M | 1,191.39%167.92M |
| Operating profit | 27.77%-304.86M | 19.01%-85.13M | 53.47%-43.94M | -117.88%-93.03M | 53.97%-82.77M | -510.10%-422.06M | -360.78%-105.11M | -513.30%-94.42M | -186.82%-42.7M | -1,018.02%-179.83M |
| Net non-operating interest income expense | 2.14%31.21M | -39.65%6.08M | -28.25%7.54M | 26.36%8.45M | 177.36%9.15M | 654.07%30.56M | 279.53%10.07M | 965.11%10.5M | 1,518.64%6.69M | 3.3M |
| Non-operating interest income | 2.14%31.21M | -39.65%6.08M | -28.25%7.54M | 26.36%8.45M | 177.36%9.15M | 654.07%30.56M | 279.53%10.07M | 965.11%10.5M | 1,518.64%6.69M | --3.3M |
| Other net income (expense) | 157.69%25.43M | 110.06%17K | -63,821.05%-12.15M | -110.97%-1.09M | 45,913.10%38.65M | 2,679.72%9.87M | -148.01%-169K | -575.00%-19K | 997,300.00%9.97M | 84K |
| Gain on sale of security | ---- | ---- | ---- | ---- | ---- | 2,013.14%10.29M | --0 | ---- | --10.14M | --147K |
| Special income (charges) | ---11.39M | ---585K | ---10.81M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Less：Restructuring and merger&acquisition | --11.39M | --585K | --10.81M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Other non- operating income (expenses) | 8,805.20%36.82M | 456.21%602K | -6,931.58%-1.34M | -536.05%-1.09M | 61,450.79%38.65M | -220.45%-423K | -25.19%-169K | -575.00%-19K | -17,100.00%-172K | ---63K |
| Income before tax | 34.96%-248.23M | 16.99%-79.03M | 42.16%-48.55M | -229.01%-85.67M | 80.18%-34.97M | -489.21%-381.64M | -380.70%-95.21M | -482.67%-83.94M | -79.90%-26.04M | -996.98%-176.45M |
| Income tax | ||||||||||
| Net income | 34.96%-248.23M | 16.99%-79.03M | 42.16%-48.55M | -229.01%-85.67M | 80.18%-34.97M | -489.21%-381.64M | -380.70%-95.21M | -482.67%-83.94M | -79.90%-26.04M | -996.98%-176.45M |
| Net income continuous Operations | 34.96%-248.23M | 16.99%-79.03M | 42.16%-48.55M | -229.01%-85.67M | 80.18%-34.97M | -489.21%-381.64M | -380.70%-95.21M | -482.67%-83.94M | -79.90%-26.04M | -996.98%-176.45M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 34.96%-248.23M | 16.99%-79.03M | 42.16%-48.55M | -229.01%-85.67M | 80.18%-34.97M | -489.21%-381.64M | -380.70%-95.21M | -482.67%-83.94M | -79.90%-26.04M | -996.98%-176.45M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 34.96%-248.23M | 16.99%-79.03M | 42.16%-48.55M | -229.01%-85.67M | 80.18%-34.97M | -489.21%-381.64M | -380.70%-95.21M | -482.67%-83.94M | -79.90%-26.04M | -996.98%-176.45M |
| Basic earnings per share | 53.96%-2.5 | -5.33%-0.79 | 43.68%-0.49 | -115.00%-0.86 | 80.17%-0.36 | -71.38%-5.43 | 22.59%-0.75 | -23.46%-0.87 | 43.50%-0.4 | -130.72%-1.8153 |
| Diluted earnings per share | 53.96%-2.5 | -5.33%-0.79 | 43.68%-0.49 | -115.00%-0.86 | 80.17%-0.36 | -71.38%-5.43 | 22.59%-0.75 | -23.46%-0.87 | 43.50%-0.4 | -130.72%-1.8153 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings